CRC
PCVX icon

Curi RMB Capital’s Vaxcyte PCVX Stock Holding History

Curi RMB Capital’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-13,213
Closed -$499K – 681
2025
Q1 		$499K Buy
13,213
+4,597
+53% +$368K 0.01% 387
2024
Q4 		$705K Buy
8,616
+715
+9% +$71K 0.02% 372
2024
Q3 		$903K Buy
+7,901
New +$712K 0.02% 350

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Curi RMB Capital's PCVX Position: Q2 2025 in Review

Curi RMB Capital sold out of Vaxcyte (PCVX) in Q2 2025, closing a stake of 13,213 shares — an estimated $499K sold.

Curi RMB Capital first reported a position in PCVX in Q3 2024 and held it in 3 quarters. The position peaked at $903K in Q3 2024. 294 funds tracked by Wall St. Rank hold PCVX as of Q2 2025.

  • Curi RMB Capital reported no remaining Vaxcyte position as of Q2 2025 after selling out during the quarter.
  • Curi RMB Capital sold 13,213 Vaxcyte shares in Q2 2025, an estimated $499K.
  • Curi RMB Capital first reported a position in Vaxcyte in Q3 2024 and held it in 3 quarters.
  • Curi RMB Capital's Vaxcyte position peaked at $903K in Q3 2024.
  • 294 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2025.

Based on Curi RMB Capital's 13F filing for Q2 2025, filed 14 Aug 2025.